Response to Multiple Radiation Doses of Human Colorectal Carcinoma Cells Infected with Recombinant Adenovirus Containing Dominant-negative Ku70 Fragment

Overview

Journal Int J Radiat Oncol Biol Phys

Specialties Oncology
Radiology

Date 2010 Jun 1

PMID 20510198

Citations 2

Authors

Muneyasu Urano

Fuqiu He

Akiko Minami

C Clifton Ling

Gloria C Li

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate the effect of recombinant replication-defective adenovirus containing dominant-negative Ku70 fragment on the response of tumor cells to multiple small radiation doses. Our ultimate goal is to demonstrate the feasibility of using this virus in gene-radiotherapy to enhance the radiation response of tumor cells.

Methods And Materials: Human colorectal HCT8 and HT29 carcinoma cells were plated in glass tubes, infected with virus (25 multiplicity of infection), and irradiated with a single dose or zero to five doses of 3 Gy each at 6-h intervals. Hypoxia was induced by flushing with 100% nitrogen gas. The cells were trypsinized 0 or 6 h after the final irradiation, and cell survival was determined by colony formation. The survival data were fitted to linear-quadratic model or exponential line.

Results: Virus infection enhanced the radiation response of the HCT8 and HT29 cells. The virus enhancement ratio for single-dose irradiation at a surviving fraction of 0.1 was approximately 1.3 for oxic and hypoxic HCT8 and 1.4 and 1.1 for oxic and hypoxic HT29, respectively. A similar virus enhancement ratio of 1.2-1.3 was observed for both oxic and hypoxic cells irradiated with multiple doses; however, these values were smaller than the values found for dominant-negative Ku70-transfected Rat-1 cells. This difference has been discussed. The oxygen enhancement ratio for HCT8 and HT29 receiving fractionated doses was 1.2 and 2.0, respectively, and virus infection altered them slightly.

Conclusion: Infection of recombinant replication-defective adenovirus containing dominant-negative Ku70 fragment enhanced the response of human colorectal cancer cells to single and multiple radiation doses.

Citing Articles

A bioinformatics filtering strategy for identifying radiation response biomarker candidates.

Oh J, Wong H, Wang X, Deasy J PLoS One. 2012; 7(6):e38870.

PMID: 22768051 PMC: 3387230. DOI: 10.1371/journal.pone.0038870.

Mycobacterium tuberculosis Ku can bind to nuclear DNA damage and sensitize mammalian cells to bleomycin sulfate.

Castore R, Hughes C, Debeaux A, Sun J, Zeng C, Wang S Mutagenesis. 2011; 26(6):795-803.

PMID: 21811007 PMC: 3198890. DOI: 10.1093/mutage/ger049.

References

Utsumi H, Elkind M . Requirement for repair of DNA double-strand breaks by homologous recombination in split-dose recovery. Radiat Res. 2001; 155(5):680-6. DOI: 10.1667/0033-7587(2001)155[0680:rfrodd]2.0.co;2. View

Li G, He F, Shao X, Urano M, Shen L, Kim D . Adenovirus-mediated heat-activated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo. Cancer Res. 2003; 63(12):3268-74. View

Smider V, Rathmell W, Lieber M, Chu G . Restoration of X-ray resistance and V(D)J recombination in mutant cells by Ku cDNA. Science. 1994; 266(5183):288-91. DOI: 10.1126/science.7939667. View

Walker J, Corpina R, Goldberg J . Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature. 2001; 412(6847):607-14. DOI: 10.1038/35088000. View

Gu Y, Jin S, Gao Y, Weaver D, Alt F . Ku70-deficient embryonic stem cells have increased ionizing radiosensitivity, defective DNA end-binding activity, and inability to support V(D)J recombination. Proc Natl Acad Sci U S A. 1997; 94(15):8076-81. PMC: 21559. DOI: 10.1073/pnas.94.15.8076. View

Singleton B, Priestley A, Steingrimsdottir H, Gell D, Blunt T, Jackson S . Molecular and biochemical characterization of xrs mutants defective in Ku80. Mol Cell Biol. 1997; 17(3):1264-73. PMC: 231851. DOI: 10.1128/MCB.17.3.1264. View

Errami A, Smider V, Rathmell W, He D, Hendrickson E, Zdzienicka M . Ku86 defines the genetic defect and restores X-ray resistance and V(D)J recombination to complementation group 5 hamster cell mutants. Mol Cell Biol. 1996; 16(4):1519-26. PMC: 231136. DOI: 10.1128/MCB.16.4.1519. View

Ayene I, Ford L, Koch C . Ku protein targeting by Ku70 small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and gamma radiation. Mol Cancer Ther. 2005; 4(4):529-36. DOI: 10.1158/1535-7163.MCT-04-0130. View

Gullo C, Au M, Feng G, Teoh G . The biology of Ku and its potential oncogenic role in cancer. Biochim Biophys Acta. 2006; 1765(2):223-34. DOI: 10.1016/j.bbcan.2006.01.001. View

10.

He F, Li L, Kim D, Wen B, Deng X, Gutin P . Adenovirus-mediated expression of a dominant negative Ku70 fragment radiosensitizes human tumor cells under aerobic and hypoxic conditions. Cancer Res. 2007; 67(2):634-42. DOI: 10.1158/0008-5472.CAN-06-1860. View

11.

Tuteja R, Tuteja N . Ku autoantigen: a multifunctional DNA-binding protein. Crit Rev Biochem Mol Biol. 2000; 35(1):1-33. DOI: 10.1080/10409230091169177. View

12.

Thames Jr H, Withers H, Peters L, FLETCHER G . Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys. 1982; 8(2):219-26. DOI: 10.1016/0360-3016(82)90517-x. View

13.

Sah N, Munshi A, Nishikawa T, Mukhopadhyay T, Roth J, Meyn R . Adenovirus-mediated wild-type p53 radiosensitizes human tumor cells by suppressing DNA repair capacity. Mol Cancer Ther. 2003; 2(11):1223-31. View

14.

Urano M, Huang Y, He F, Minami A, Ling C, Li G . Response to multiple radiation doses of fibroblasts over-expressing dominant negative Ku70. Int J Radiat Oncol Biol Phys. 2008; 71(2):533-41. PMC: 2723945. DOI: 10.1016/j.ijrobp.2007.12.061. View

15.

Valerie K, Povirk L . Regulation and mechanisms of mammalian double-strand break repair. Oncogene. 2003; 22(37):5792-812. DOI: 10.1038/sj.onc.1206679. View

16.

Nussenzweig A, SOKOL K, Burgman P, Li L, Li G . Hypersensitivity of Ku80-deficient cell lines and mice to DNA damage: the effects of ionizing radiation on growth, survival, and development. Proc Natl Acad Sci U S A. 1998; 94(25):13588-93. PMC: 28350. DOI: 10.1073/pnas.94.25.13588. View

17.

Negroni A, Stronati L, Grollino M, Barattini P, Gumiero D, Danesi D . Radioresistance in a tumour cell line correlates with radiation inducible Ku 70/80 end-binding activity. Int J Radiat Biol. 2008; 84(4):265-76. DOI: 10.1080/09553000801953318. View

18.

Kurimasa A, Ouyang H, Dong L, Wang S, Li X, Cordon-Cardo C . Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis. Proc Natl Acad Sci U S A. 1999; 96(4):1403-8. PMC: 15475. DOI: 10.1073/pnas.96.4.1403. View

19.

Nussenzweig A, Chen C, da Costa Soares V, Sanchez M, SOKOL K, Nussenzweig M . Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature. 1996; 382(6591):551-5. DOI: 10.1038/382551a0. View

20.

Taccioli G, Gottlieb T, Blunt T, Priestley A, Demengeot J, Mizuta R . Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science. 1994; 265(5177):1442-5. DOI: 10.1126/science.8073286. View